Dun Liang

Global Regulatory Affairs, Diagnostics Eli Lilly & Co.

Seminars

Monday 22nd September 2025
Panel Discussion: Why Diagnostic Regulation Matters in Pharmaceutical Development, & Current Best Practices
5:30 pm
  • Identifying the role of diagnostics in pharmaceutical development and the corresponding levels of regulatory expectation
  • Providing a high-level summary and comparison of related regulations globally
  • Outlining best practices for aligning diagnostic and therapeutic development processes to foster innovation and ensure patient access to precision therapies
Dun Liang